Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Maryam Fouladi, MD |
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry |
The Cure Starts Now Foundation |
DIPG - Fouladi |
01/01/2012 - 12/31/2018 |
$233,311 |
Maryam Fouladi, MD |
Pediatric Brain Tumor Consortium (PBTC) |
National Institutes of Health (St Jude's Children's Hospital) |
UM1 CA081457 |
04/01/2014 - 03/31/2019 |
$92,745 |
Maryam Fouladi, MD |
Pediatric Brain Tumor Consortium (PBTC) |
National Institutes of Health (St Jude's Children's Hospital) |
UM1 CA081457 |
04/01/2014 - 03/31/2019 |
$39,000 |
Brian D Weiss, MD |
COG NCTN Network Group Operations Center |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
04/11/2014 - 02/28/2019 |
$23,108 |
Maryam Fouladi, MD |
COG NCTN Network Group Operations Center |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
04/11/2014 - 02/28/2019 |
$7,500 |
Adrienne Hammill, MD |
Brain Vascular Malformation Consortium: Predictors of Clinical Course |
National Institutes of Health (The Regents of the Univ of California) |
U54 NS065705 |
09/30/2014 - 07/31/2019 |
$4,212 |
John P Perentesis, MD |
COG NCORP Research Base: Per case Reimbursement |
National Institutes of Health (Children's Hospital of Philadelphia) |
UG1 CA189955 |
08/01/2014 - 07/31/2018 |
$50,000 |
Susanne Wells, PhD |
Targeting Lipid Metabolism in FA for the Prevention and Treatment of Squamous Cell Carcinoma. |
Fanconi Anemia Research Fund |
Wells, Sue, FARF |
03/01/2016 - 02/28/2018 |
$125,000 |
Sonya Ruiz-Torres |
Role of the Fanconi Anemia DNA Repair Pathway in Epidermal Stem and Progenitor Cells and Squamous Cell Carcinoma |
National Institutes of Health |
F31 AR070008 |
09/01/2016 - 08/31/2019 |
$37,176 |
Erin Haag Breese, MD, PhD |
Total Therapy for Infants with Acute Lymphoblastic Leukemia (ALL) “TINI” |
St Jude's Children's Hospital |
TINI |
03/01/2016 - 02/29/2020 |
$31,001 |
Brian D Weiss, MD |
A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; HYD SULFATE) in Children with Neurofibromatosis Type I (NF1) and Inoperable Plexiform Neurofibromas (PN) |
Johns Hopkins School of Medicine |
2002883540 |
01/01/2016 - 12/31/2018 |
$123,071 |
Brian D Weiss, MD |
A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; HYD SULFATE) in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) |
Johns Hopkins School of Medicine |
2001824052 |
01/01/2016 - 12/31/2018 |
$137,500 |
Biplab DasGupta, PhD |
Biguanide Sensitivity of Glioma Stem Cells |
National Institutes of Health |
R01 NS099162 |
02/01/2016 - 11/30/2021 |
$347,942 |
Christine L Phillips, MD |
Pembrolizumab in Combination with Decitabine in Relapsed/Refractory Pediatric Myeloid Leukemia |
Cancer Free Kids |
Phillips, Christine, |
07/01/2016 - 06/30/2018 |
$25,000 |
Benjamin Mizukawa, MD |
The Lesser of Two Evils: Weakening Infant Leukemia Through Forced Lineage Switch |
Cancer Free Kids |
50000 |
07/01/2016 - 06/30/2018 |
$50,000 |
Benjamin Mizukawa, MD |
Precision Medicine in a Pediatric Leukemia Avatar System |
St. Baldrick's Foundation |
CDA |
07/01/2016 - 06/30/2018 |
$115,000 |
Elizabeth A Gilger, APRN, CNP |
Prospective Symptom Assessment in Children with Advanced Cancer |
Alex's Lemonade Stand Foundation (University of Wisconsin-Madison) |
gilger, beth, als |
01/15/2016 - 01/14/2018 |
$9,998 |
Biplab DasGupta, PhD |
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase |
National Institutes of Health |
R01 NS072591 |
07/01/2016 - 06/30/2017 |
$334,688 |
Susanne Wells, PhD |
Role and Regulation of the Human DEK Proto-Oncogene |
National Institutes of Health |
R01 CA116316 |
07/01/2016 - 06/30/2018 |
$265,615 |
Noor A Nassef |
Diffuse Intrinsic Pontine Glioma |
Joshua's Wish |
|
07/01/2016 - 06/30/2018 |
$5,000 |
Lisa Marie Privette Vinnedge, PhD |
Exploring the Role of the Oncogene Dek as a Novel Player in Alzheimer’s Disease |
Life Sciences Research Foundation (University of Cincinnati) |
life2016 |
09/01/2016 - 08/31/2018 |
$8,032 |
Maureen O'Brien, MD |
T2012-002: A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo®) in Combination with UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults with Relapse of Acute Lymphoblastic Leukemia |
Children's Hospital Los Angeles |
T2012002 |
09/01/2016 - 08/31/2020 |
$10,843 |
Rachid Drissi, PhD |
Induced Telomere Damage to Treat Poor-Prognosis Pediatric Brain Tumors |
University of Cincinnati |
Drissi, Rachid, UC |
07/01/2016 - 06/30/2018 |
$25,000 |
James Geller, MD |
COG NCTN Network Group Operations Center |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
03/01/2016 - 02/28/2019 |
$15,000 |
Adrienne Hammill, MD |
Lymphatic Anomalies Registry |
Children's Hospital Boston |
hammill, andrienne, |
10/01/2016 - 09/30/2018 |
$20,000 |
Maureen O'Brien, MD |
Study Chair: NIH Clinical Trials Network (NCTN) |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
03/01/2016 - 02/28/2019 |
$23,366 |
Rajaram Nagarajan, MD |
Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer ALTE1621 |
National Institutes of Health (Children's Hospital of Philadelphia) |
R01 CA196854 |
07/01/2016 - 06/30/2020 |
$16,200 |
Maryam Fouladi, MD |
Scientific Leadership NCTN grant |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
09/01/2016 - 02/28/2021 |
$27,876 |
Maryam Fouladi, MD |
Central Nervous System Tumor Committee |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
07/01/2016 - 03/31/2017 |
$52,500 |
John P Perentesis, MD |
NCTN Adolescent Young Adult Committee |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
07/01/2016 - 02/28/2017 |
$7,501 |
James Geller, MD |
NCTN Committee Leadership |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
07/01/2016 - 02/28/2017 |
$7,501 |
Maryam Fouladi, MD |
Brain Tumor Center - Radio Genomics |
Curing Kids Cancer |
CKC2016 |
01/01/2017 - 12/31/2017 |
$60,000 |
John P Perentesis, MD |
A Phase I/II Trial of Ganetespib in combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors |
Sarcoma Alliance for Res through Collabo |
Perentesis, John, SA |
03/01/2017 - 02/29/2020 |
$25,001 |
John P Perentesis, MD |
EveryChild (APEC14B1) |
Children's Oncology Group (Children's Hospital of Philadelphia) |
APEC14B1 |
10/26/2015 - 10/25/2019 |
$15,000 |
Peter Matthew Kennedy de Blank, MD |
Radiographic Biomarkers for Residual Disease in Pediatric Brain Tumors |
St. Baldrick's Foundation |
318690 |
02/01/2017 - 06/30/2017 |
$57,460 |
Total Annual Grant Award Dollars |
$2,428,147 |